CULT Food Science and Umami Bioworks Reveal World';s First Cat Treat with Cell-Cultivated Fish
- Marina Cat™ introduces a unique hybrid cell-cultivated pet food brand for cats, addressing the strain on the global fish supply caused by the cat food industry.
- The treat contains omega 3, 6, and 9 fatty acids that can boost brain, vision, and nervous system development in cats and kittens.
- Marina Cat™ is expected to have widespread availability in 2024, marking a world first for the pet food industry.
- The release of Marina Cat™ represents a significant opportunity in the $150B global pet food market.
- None.
Hybrid pet food brand "Marina Cat" slated for 2024 release uses a mix of ocean snapper and Bmmune®
Marina Cat™ is a blend of ocean snapper, cultivated by
Human impact on the oceans extends beyond our own consumption of seafood. Cats, in particular, are obligate carnivores; their bodies do not digest plants well enough to provide enough nutrients for their survival. Pet owners simply cannot avoid feeding their cats animal products to meet their basic nutritional needs which causes a surprising amount of strain on the global fish supply. In 20081 it was estimated that the amount of raw fishery products directly used by the cat food industry equates to 2.48 million metric tonnes per year. Marina Cat™ has all the animal-derived nutrition of caught or farmed fish, but none of the harmful environmental impacts of commercial fishing.
Production of Marina Cat™ products is expected to begin later this year with widespread availability anticipated in 2024. This groundbreaking release represents a world first for the pet food industry, an estimated
__________________________ |
"My vision for the future is that we no longer have to slaughter other animals to feed our cats," said Joshua Errett, VP of Product at CULT. "This brand brings me one very great step closer to making that a reality."
"We are pleased to be embarking on this partnership with Marina Cat to power a new category of cultivated pet food products that are healthier for cats and better for our oceans. As a platform technology provider, we are committed to delivering the technology stack that powers commercialization of cultivated products across a range of applications. This first collaboration with Marina Cat and CULT Food Science is the first step to delivering on that promise," said Mihir Pershad, CEO of Umami Bioworks.
CULT Food Science Corp. is the first publicly-traded company of its kind in
UMAMI Bioworks is building the development and manufacturing platform for the scalable production of cultivated seafood that keeps endangered, threatened, and protected (ETP) species in the ocean while providing consumers with sustainable seafood without compromises. Through systems engineering-led thinking, we will accelerate discovery and industrialization and enable local, price competitive, scaled production of novel cell cultivation products with our automated modular production system. For more information, visit https://www.umamibioworks.com.
Additional information can be found by viewing the Company's website at cultfoodscience.com or its regulatory filings on sedar.com.
On behalf of the Board of Directors of the Company,
CULT FOOD SCIENCE CORP.
"Lejjy Gafour"
Lejjy Gafour, Chief Executive Officer
Web: CULTFoodScience.com
Twitter: @CULTFoodScience
Information set forth in this news release may involve forward-looking statements. Forward-looking statements are statements that relate to future, not past, events. In this context, forward-looking statements often address a company's expected future business and financial performance, and often contain words such as "anticipate", "believe", "plan", "estimate", "expect", and "intend", statements that an action or event "may", "might", "could", "should", or "will" be taken or occur, or other similar expressions. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include but are not limited to the following risks: those associated with marketing and sale of securities; the need for additional financing; reliance on key personnel; the potential for conflicts of interest among certain officers or directors with certain other projects; and the volatility of common share price and volume. Forward-looking statements are made based on management's beliefs, estimates and opinions on the date that statements are made and except as required by law, the Company undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change. Investors are cautioned against attributing undue certainty to forward-looking statements. For further information on risk, investors are advised to see the Company's MD&A and other disclosure filings with the regulators which are found at sedar.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/cult-food-science-and-umami-bioworks-reveal-worlds-first-cat-treat-with-cell-cultivated-fish-301903243.html
SOURCE CULT Food Science Corp.
FAQ
What is the name of the hybrid cell-cultivated pet food brand for cats?
What are the main ingredients of Marina Cat™?
What are the nutritional benefits of Marina Cat™?
When will Marina Cat™ be available?
What is the estimated market size for pet food?
